Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to ...

Researchers have identified WSTF as a key protein driving chronic inflammation, offering a potential target to treat ...

For decades, scientists have identified chronic low-level inflammation – called “inflammaging” – as one of the primary ...

Inflammaging might not be a universal feature of ageing after all. Instead, it could be a byproduct of how we live in modern ...